Editorial Board
Xudong Huang PhD (Massachusetts Institute of Technology); MS (Tufts University); BS (University of Science and Technology of China)
Senior Investigator, Massachusetts General Hospital, Boston, MA · United States
Editorial leadership for Journal of Alzheimer's Research and Therapy ISSN 2998-4211
Research interests
- His Current Research Thrust Is To High-Throughput Screen
- Design
- Synthesize
- And Characterize Targeted Theranostic Compounds For Human Diseases Such As Alzheimer’s Disease
- Cancer
- And Cardiovascular Diseases
- Etc. In Addition
- His Lab Is Exploring Novel Applications Of Biomedical Informatics (Such As Medical Image Analysis
- Bioinformatics)
- Cheminformatics (Such As Structure-Based Rational Drug Design
- In-Silico Drug Screening) In Systems Biology
- Nanotechnology In Translational Medicine
Biography
- Dr. Xudong Huang is an assistant professor of Harvard Medical School (HMS), and the Co-director for Neurochemistry Lab at Psychiatry Department of Massachusetts General Hospital (MGH).
- Dr. Huang received his PhD from MIT (Nuclear Science and Engineering). He performed his postdoctoral work at Massachusetts General Hospital MGH/HMS.
- His current research thrust is to high-throughput screen and design, synthesize, and characterize targeted theranostic compounds for human diseases such as Alzheimer’s disease, cancer, and cardiovascular diseases, etc.
- In addition, his lab is exploring novel applications of biomedical informatics (such as medical image analysis and bioinformatics) and cheminformatics (such as structure-based rational drug design and in-silico drug screening) in systems biology and nanotechnology in translational medicine.
- Dr. Huang serves on scientific advisory and editorial boards for several research foundations and many scientific journals.
Selected publications
- Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism 2020 cited 176×
- Network Medicine for Alzheimer’s Disease and Traditional Chinese Medicine 2018 cited 57×
- A Concise Review on Oxidative Stress-Mediated Ferroptosis and Cuproptosis in Alzheimer’s Disease 2023 cited 41×
- Designing Socially Assistive Robots for Alzheimer’s Disease and Related Dementia Patients and Their Caregivers: Where We Are and Where We Are Headed 2020 cited 41×
- Current Cognition Tests, Potential Virtual Reality Applications, and Serious Games in Cognitive Assessment and Non-Pharmacological Therapy for Neurocognitive Disorders 2020 cited 40×
- Overcoming Alzheimer’s Disease Stigma by Leveraging Artificial Intelligence and Blockchain Technologies 2020 cited 32×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JALR for your work?
This journal is guided by Xudong Huang (Senior Investigator, Massachusetts General Hospital, Boston, MA) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.